Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ondansetron in the treatment of schizophrenia
IRCT20180505039530N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ondansetron in schizophrenia, sponsored by Kashan University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
ondansetron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20180505039530N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180505039530N1.